Saqib Islam
Algemeen Directeur bij SPRINGWORKS THERAPEUTICS, INC.
Vermogen: 35 M $ op 30-04-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Stephen P. Squinto | M | 67 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 31 jaar |
Daniel Lynch | M | 65 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 8 jaar |
Edgar Cale | M | 60 | 5 jaar | |
Yung-Shin Alexander Kung | M | - |
Credit Suisse Asset Management LLC
Credit Suisse Asset Management LLC Investment ManagersFinance Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland. | 15 jaar |
Richard Lowenthal | M | 58 | 9 jaar | |
Daniel Simkowitz | M | 57 | 24 jaar | |
Jeffrey Schwartz | M | 45 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 7 jaar |
Maxine Gowen | M | 66 | 3 jaar | |
Eric Grossman | M | 57 | 18 jaar | |
Stéphane Bancel | M | 51 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
William Chou | M | 51 | 2 jaar | |
Michael Rongetti | M | - |
Credit Suisse Asset Management LLC
Credit Suisse Asset Management LLC Investment ManagersFinance Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland. | 12 jaar |
Shannon Klinger | M | 53 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
James Gorman | M | 65 | 18 jaar | |
Alan Fuhrman | M | 67 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 5 jaar |
Deval Patrick | M | 67 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 3 jaar |
Freda Lewis-Hall | M | 69 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 7 jaar |
Rajeev Dadoo | M | 54 | 3 jaar | |
Kim Diamond | F | - | 6 jaar | |
Robert Bell | M | - | 9 jaar | |
Sarina Tanimoto | M | 55 | 9 jaar | |
Derrell Porter | M | 53 | 3 jaar | |
James M. Wilson | M | - | 7 jaar | |
Frederick Pollock | M | 44 | 18 jaar | |
Kathleen Borthwick | F | 48 | 3 jaar | |
Sandipkumar S. Kapadia | M | 54 | 5 jaar | |
Herschel Weinstein | M | 68 | 4 jaar | |
Badreddin Edris | M | 37 | 6 jaar | |
Stephen Hoge | M | 48 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
Brian Dorsey | M | 55 | 6 jaar | |
Justin Chakma | M | 35 | 5 jaar | |
Peter Thompson | M | 64 | 2 jaar | |
Pratik Shah | M | 54 | 8 jaar | |
Phillip Schneider | M | 68 | 5 jaar | |
Alexander Fitzpatrick | M | 57 | 2 jaar | |
Peter Kolchinsky | M | 47 | 3 jaar | |
Michael Kelly | M | 59 | 5 jaar | |
Carlos Alban | M | 61 | 2 jaar | |
Stuart M. Henderson | M | - | 3 jaar | |
Athena Countouriotis | M | 52 | 4 jaar | |
Julie Hambleton | M | 66 | 4 jaar | |
Eric Karas | M | 52 | 2 jaar | |
Bhavesh Ashar | M | 58 | 3 jaar | |
James Cassidy | M | 65 | 3 jaar | |
Jack Szostak | M | - |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
Mandell Crawley | M | 48 | 20 jaar | |
Mark Forman | M | 60 | 3 jaar | |
Brenton Saunders | M | 56 | 3 jaar | |
Daniel Pichl | M | 41 | 4 jaar | |
Daniel Relovsky | M | - | 2 jaar | |
Frank Ducomble | M | - | 18 jaar | |
Michael Nofi | M | 53 | 5 jaar | |
Marcello Damiani | M | 54 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | - |
Lorence Kim | M | 49 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 10 jaar |
Kathleen Scott | F | 55 | 2 jaar | |
Laura Shawver | M | 66 | 2 jaar | |
Peter Hutt | M | 89 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 12 jaar |
Frank Perier | M | 64 | 5 jaar | |
Sarah Marshall | F | - | 10 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Bruce Goldsmith | M | 58 | 2 jaar | |
David Brennan | M | 70 | 7 jaar | |
Joseph A. Madri | M | 80 | 22 jaar | |
Michael Altman | M | 42 | 1 jaar | |
Robert Scott | M | 78 | 2 jaar | |
Jim Kasinger | M | 52 |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | 3 jaar |
Thomas R. Nides | M | 63 | 5 jaar | |
Jonathan Pruzan | M | 55 | 18 jaar | |
Lara Sullivan | M | 51 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 1 jaar |
Adam Stone | M | 44 | 1 jaar | |
Mark Day | M | 52 | 2 jaar | |
Konstantin Poukalov | M | 40 | 1 jaar | |
John Carl Hahn | M | 66 | 11 jaar | |
Israel Ruiz | M | 52 | - | |
Michael V. Greco | M | 53 | 1 jaar | |
Jens Renstrup | M | 59 | 6 jaar | |
L. Smith | M | 57 | 7 jaar | |
Lisa Lejuwaan | F | - | - | |
Juan Andres | M | 59 | 6 jaar | |
Scott Peters | M | - | 8 jaar | |
Ruth Porat | F | 66 | 12 jaar | |
Liam Ratcliffe | M | 60 | 3 jaar | |
Felix Baker | M | 55 | 6 jaar | |
Jordan Low | M | - |
Credit Suisse Asset Management LLC
Credit Suisse Asset Management LLC Investment ManagersFinance Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland. | 4 jaar |
Joseph Edelman | M | 67 | 1 jaar | |
Larry L. Mathis | M | 80 | 10 jaar | |
Bradley Campbell | M | 48 | - | |
Michael Kamarck | M | 73 | 1 jaar | |
Jonathan Leff | M | 55 | 5 jaar | |
M. Burns | F | 66 | 4 jaar | |
Carl Gordon | M | 59 | 2 jaar | |
Max E. Link | M | 84 | 22 jaar | |
Christopher Coughlin | M | 71 | 7 jaar | |
Gary W. Parr | M | 67 | 9 jaar | |
Eileen Murray | F | 66 | 2 jaar | |
William Keller | M | 75 | 6 jaar | |
Moncef Slaoui | M | 64 | 3 jaar | |
Jack Mollen | M | 73 | 7 jaar | |
Thomas Woiwode | M | 52 | 5 jaar | |
Klaus Svendsen | M | - | 3 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 99 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Saqib Islam
- Persoonlijk netwerk